• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION COREVALVE REVALVING SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION COREVALVE REVALVING SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number CRS-P3-943
Device Problem Perivalvular Leak (1457)
Patient Problems Congestive Heart Failure (1783); Death (1802); Endocarditis (1834); Fever (1858); Sepsis (2067); Pseudoaneurysm (2605); No Code Available (3191)
Event Date 09/28/2014
Event Type  Death  
Event Description
Medtronic received information from a journal article that a patient implanted with a transcatheter bioprosthetic heart valve was diagnosed with endocarditis approximately seven months after device implant via transfemoral access.A review of the journal article summary and the original article indicated that the patient presented with acute congestive heart failure and a fever.The patient¿s previous medical history included coronary artery bypass grafting and implantation of another manufacturer¿s prosthetic mitral valve approximately 17 months prior to the aortic valve replacement.The screening on admission before the aortic valve procedure revealed nasal colonization with (b)(6).A decolonization regimen with mupirocin nasal ointment was carried out, and surveillance cultures were (b)(6).Three separate blood cultures were (b)(6).Oscillating intra-cardiac masses could be detected neither on the prosthetic mitral valve nor on the aortic device.However, this device showed a relevant dynamic paravalvular leak that enlarged in diastole, causing deformation of the prosthesis.In addition, diffuse thickening of the aortic root and a discontinuity in the native aortic annulus were present, resulting in the treating physicians¿ diagnosis of an aortic root abscess with a pseudoaneurysm.The patient was treated with antibiotic therapy.The patient expired 18 days later due to sepsis and cardiac decompensation.The patient¿s family refused an autopsy.
 
Manufacturer Narrative
The date of death was not reported in the article; an arbitrary date of the first of the year of the article's reported year of death is populated here to facilitate electronic submission of the report.Medtronic¿s databases were reviewed in an attempt to determine if these this complaint had previously been reported to medtronic, based on the limited information available; there were no indications that the complaint information had previously been provided to medtronic.It was reported that the device was not explanted.(b)(4).Original article: prosthetic valve endocarditis after transcatheter aortic valve implantation: the incidence in a single-centre cohort and reflections on clinical, echocardiographic and prognostic features authors: miriam puls, md; helmut eiffert, md; mark hünlich, md; friedrich schöndube, md; gerd hasenfuss, md; ralf seipelt, md; wolfgang schillinger, md department of cardiology, georg august university of goettingen, goettingen, germany; department of microbiology, georg august university of goettingen, goettingen, germany; department of cardiovascular surgery, georg august university of goettingen, goettingen, germany.Cited in: transcatheter heart valve failure: a systematic review authors: darren mylotte, ali andalib, pascal the´riault-lauzier, magdalena dorfmeister, mina girgis,waleed alharbi, michael chetrit, christos galatas, samuel mamane, igal sebag, jean buithieu, luc bilodeau, benoit de varennes, kevin lachapelle, ruediger lange, giuseppe martucci, renu virmani, and nicolo piazza european heart journal doi:10.1093/eurheartj/ehu388 september 28, 2014.
 
Manufacturer Narrative
The reported clinical events in the article are known potential adverse events for bioprosthetic valves (surgical or transcatheter).Without device-identifying information, a review of device history manufacturing and sterilization records could not be performed.A mechanism of failure could not be determined due to the limited amount of information available.
 
Manufacturer Narrative
Corrected information: no eval explain code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COREVALVE REVALVING SYSTEM
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4381897
MDR Text Key5291363
Report Number2025587-2015-00026
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,foreign,health profe
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 07/28/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCRS-P3-943
Device Catalogue NumberCRS-P3-943
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/28/2015
Initial Date FDA Received01/05/2015
Supplement Dates Manufacturer ReceivedNot provided
07/28/2015
Supplement Dates FDA Received07/31/2015
09/15/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age00080 YR
-
-